logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table HSR-6. Hepatitis responses in the EU, Croatia, Turkey and Norway

Part (ii) Availability of Hepatitis C testing

CountryHepatitis C testing in the communityHepatitis C testing in prison: at entryHepatitis C testing in prison: at release
Belgium (Flemish community)ExtensiveFullLimited
Belgium (French community)ExtensiveLimitedNot available
BulgariaExtensiveNo informationNo information
Czech RepublicExtensiveRareRare
DenmarkNo informationNo informationNo information
GermanyNo informationNo informationNo information
EstoniaNo informationFullFull
IrelandExtensiveLimitedExtensive
GreeceExtensiveFullNot available
SpainExtensiveExtensiveExtensive
FranceFullExtensiveNo information
ItalyFullNo informationNo information
CyprusFullFullNot available
LatviaLimitedNot availableNot available
LithuaniaLimitedLimitedNot available
LuxembourgLimitedFullRare
Hungary(1)ExtensiveNot availableNot available
MaltaFullFullNot available
NetherlandsLimitedLimitedNo information
AustriaLimitedExtensiveRare
PolandFullFullFull
PortugalFullExtensiveNo information
RomaniaLimitedLimitedRare
SloveniaFullExtensiveNot available
SlovakiaLimitedFullNo information
FinlandExtensiveFullFull
SwedenNo informationFullNot available
United KingdomExtensiveLimitedExtensive
CroatiaFullFullFull
TurkeyLimitedNo informationNo information
NorwayFullExtensiveNot available
 

Notes:

Reitox NFP's expert rating

Full: nearly all persons in need would obtain it

Extensive: a majority but not nearly all of them would obtain it

Limited: more than a few but not a majority of them would obtain it

Rare: just a few of them would obtain it

(1) Although there is no HCV testing both at entry and at release, since 2007 extensive campaign screening programmes take place in prisons (for details see Hungary National Report 2011, Chapter 11.3).

Sources:

Structured Questionnaire on 'prevention and reduction of health-related harm associated with drug use' (SQ23/29), submitted by NFPs in 2011.

Page last updated: Friday, 26 April 2013